SIGLEC1 and COVID-19: The DEGs identified by bioinformatics data analysis, including C1QA, C1QB, C1QC, CD163, SIGLEC1, APOE, MS4A4A, VSIG4, CCR1, and STAB1, may be therapeutic targets for the atherosclerosis caused by COVID-19.